Company Description

NeyroblastGX is developing a next-generation theranostic products for neurodegenerative and infectious diseases like Alzheimer’s disease and COVID-19. They have a platform to provide custom made human organoid culture and genetically engineered cells for studying next-generation theranostic research such as screening drug, toxicity, and disease pathology.